Table 1.
Parameters | The number of different cohorts | P values | ||||
---|---|---|---|---|---|---|
Patients with HCC (n=47) | Patients with cirrhosis (n-29) | Healthy controls (n=31) | miR-15b-5p | miR-338-5p | miR-764 | |
Sex | ||||||
Male | 44 | 12 | 18 | |||
Female | 3 | 17 | 13 | |||
Age (years) | ||||||
≥60 | 7 | 5 | 0 | |||
<60 | 41 | 24 | 31 | |||
α-fetoprotein (ng/ml) | 0.595 | 0.039 | 0.102 | |||
≥200 | 19 | |||||
<200 | 28 | |||||
Alanine aminotransferase (U/l) | 0.312 | 0.822 | 0.875 | |||
≥40 | 31 | |||||
<40 | 16 | |||||
Aspartate aminotransferase (U/l) | 0.718 | 0.555 | 0.768 | |||
≥40 | 29 | |||||
<40 | 18 | |||||
Total bilirubin(μmol/L) | 0.644 | 0.426 | 0.54 | |||
≥17.1 | 20 | |||||
<17.1 | 27 | |||||
Child-Pugh grade | 0.989 | 0.7 | 0.184 | |||
A | 44 | |||||
B | 3 | |||||
C | 0 | |||||
Tumor size (cm) | 0.346 | 0.336 | 0.026 | |||
≥5 | 26 | |||||
<5 | 21 |